Asthma treatment wasn’t always built around inhalers. It once came from poisonous plants, smoke, and a mysterious dream. In this episode, we explore the strange history of anticholinergics, tracing the path from Jimsonweed and belladonna to atropine, acetylcholine, and Otto Loewi’s discovery of “Vagusstoff.” We follow how Loewi’s frog-heart experiment helped prove that nerves communicate through chemical messengers, and how Henry Dale’s work connected those discoveries to the vagus nerve and airway constriction. We examine why early plant-based asthma remedies could open the airways while also causing dangerous side effects, and how that understanding eventually led to modern anticholinergic therapy. This episode reveals how a dream, a frog heart, and a toxic smoke helped shape the pharmacology of asthma.

• (00:00:00) - The Dream That Changed Asthma Medicine
• (00:00:58) - Types of Neurotransmitters
• (00:02:41) - Dr. Otto Loewi’s Has a Dream
• (00:04:22) - Smoking Plants for Asthma
• (00:06:02) - Jimsonweed
• (00:08:27) - Belladonna
• (00:11:36) - Atropine Isolated
• (00:13:26) - The Autonomic Nervous System
• (00:14:44) - The Vagus Nerve
• (00:17:36) - The Frog Heart Experiment
• (00:18:54) - Vagusstoff Becomes Acetylcholine
• (00:19:42) - Henry Dale and Anticholinergic
• (00:21:49) - The Problem With Inhaled Atropine
• (00:22:15) - Modern Anticholinergic Therapy
• (00:23:56) - Outro

Asthma wasn’t always a diagnosis—it was once just a word for breathlessness. In this episode, we explore how asthma evolved from a nonspecific symptom into a defined disease of the small airways. From early descriptions in Greek medicine to the pathologic insights of Morgagni and the mechanistic thinking of Henry Hyde Salter, we follow the key discoveries that shaped our understanding of asthma. We examine how airway inflammation, bronchospasm, mucus plugging, and allergic responses were gradually identified as central features of the disease. This episode sets the stage for understanding the modern pathophysiology of asthma and the therapies that followed.

• (00:00:00) - Opening: Episode Setup
• (00:01:29) - Story: A Sickly Child in the 1800s
• (00:05:57) - What Is Asthma? (Modern Definition)
• (00:06:40) - Asthma Symptoms & Triggers
• (00:08:55) - Origins of the Word “Asthma”
• (00:09:55) - Muscle Contractions: Early Clinical Observations
• (00:13:39) - Allergy & Inflammation: 20th Century Shift
• (00:14:46) - Animal Models of Asthma
• (00:18:51) - Human Trials with Histamine
• (00:20:21) - Closing

From the discovery of a mysterious blood-pressure–lowering effect in the venom of a Brazilian pit viper to the development of the first ACE inhibitor, we trace how scientists transformed a deadly toxin into lifesaving medicine. We follow the work that identified bradykinin-potentiating peptides in snake venom and revealed that angiotensin-converting enzyme could be blocked—leading to the creation of captopril and later drugs such as enalapril and lisinopril. Along the way, landmark experiments and clinical trials showed that ACE inhibitors do far more than lower blood pressure, reshaping the treatment of heart failure and chronic kidney disease by targeting maladaptive activation of the renin–angiotensin–aldosterone system.

• (00:00:00) - ACE Inhibitor Story Continues: Shutting off RAAS
• (00:01:00) - Recap: The RAAS Refresher
• (00:02:36) - Venom Mystery : Why Pit Viper Bites Cause Hypotension
• (00:05:02) - Venom and the ACE Connection: John Vane's Lab
• (00:06:20) - Interview With a Pit Viper: Snake’s Take on Pharma
• (00:09:18) - Venom Into Medicine: Turning Raw Venom into a Drug
• (00:10:04) - Captopril: The First ACE Inhibitor
• (00:11:04) - Better ACE Inhibitors: Captopril to Enalapril to Lisinopril
• (00:12:35) - Maladaptive RAAS Activation: Heart Failure Activates Renin
• (00:19:36) - Maladaptive RAAS Activation: Kidney Failure Activates Renin
• (00:24:24) - Episode Conclusion: ACE Inhibitors Transform Cardiorenal Medicine